col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


73 Results       Page 1

 [1] 
Elsevier: Immunity
  original article Date Title Authors   All Authors
1 [GO] 2022―May―13 Antibody-Mediated Neutralization of SARS-CoV-2 Henning Gruell, Kanika Vanshylla, Timm Weber, Christopher O. Barnes, Christoph Kreer, Florian Klein
2 [GO] 2022―May―10 Instructing durable humoral immunity for COVID-19 and other vaccinable diseases Deepta Bhattacharya
3 [GO] 2022―May―10 Inducing broad-based immunity against viruses with pandemic potential Alessandro Sette, Erica Ollmann Saphire
4 [GO] 2022―Apr―07 Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant Aurélien Sokal, Matteo Broketa, Giovanna Barba-Spaeth, Annalisa Meola, Ignacio Fernández, Slim Fourati, et al. (+25)
5 [GO] 2022―Apr―07 Analysis Of Memory B Cells Identifies Conserved Neutralizing Epitopes On The N-Terminal Domain Of Variant SARS-Cov-2 Spike Proteins Zijun Wang, Frauke Muecksch, Alice Cho, Christian Gaebler, Hans-Heinrich Hoffmann, Victor Ramos, et al. (+23)
6 [GO] 2022―Mar―25 A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2 Yiquan Wang, Meng Yuan, Huibin Lv, Jian Peng, Ian A. Wilson, Nicholas C. Wu
7 [GO] 2022―Feb―08 Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia Stefanie Kreutmair, Susanne Unger, Nicolás Gonzalo Núñez, Florian Ingelfinger, Chiara Alberti, Donatella De Feo, et al. (+20)
8 [GO] 2022―Jan―22 Response to Are NKT cells a useful predictor of COVID-19 severity? Stefanie Kreutmair, Burkhard Becher
9 [GO] 2022―Jan―20 SARS-CoV-2 infections in children: understanding diverse outcomes Petter Brodin
10 [GO] 2022―Jan―19 Are NKT cells a useful predictor of COVID-19 severity? Hui-Fern Koay, Nicholas A. Gherardin, Thi HO. Nguyen, Wuji Zhang, Jennifer R. Habel, Rebecca Seneviratna, et al. (+7)
11 [GO] 2022―Jan―06 mRNA-1273 vaccine-induced antibodies maintain Fc-effector functions across SARS-CoV-2 Variants of Concern Paulina Kaplonek, Stephanie Fischinger, Deniz Cizmeci, Yannic C. Bartsch, Jaewon Kang, John S. Burke, et al. (+13)
12 [GO] 2021―Dec―14 Antigenic drift: Understanding COVID-19 Jonathan W. Yewdell
13 [GO] 2021―Oct―29 Immunizations with diverse sarbecovirus receptor binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability Deborah L. Burnett, Katherine J.L. Jackson, David B. Langley, Anupria Aggrawal, Alberto Ospina Stella, Matt D. Johansen, et al. (+33)
14 [GO] 2021―Oct―13 Navigating COVID-19: Starting a lab during the pandemic José Ordovás-Montañés, Carmen Gerlach, Pedro Moraes-Vieira, Roser Vento-Tormo, Conggang Zhang, Kellie Ann Jurado
15 [GO] 2021―Sep―24 Transition to endemicity: Understanding COVID-19 Rustom Antia, M. Elizabeth Halloran
16 [GO] 2021―Sep―21 mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants Aurélien Sokal, Giovanna Barba-Spaeth, Ignacio Fernández, Matteo Broketa, Imane Azzaoui, Andrea de La Selle, et al. (+24)
17 [GO] 2021―Sep―04 Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, Michael ToVinh, Jan Raabe, Rosario Astaburuaga-García, et al. (+42)
18 [GO] 2021―Aug―25 Illuminating the Fc-dependence of SARS-CoV-2 neutralization Joseph C. González, Taia T. Wang
19 [GO] 2021―Aug―24 A SARS-CoV-2 Antibody Broadly Neutralizes SARS-related Coronaviruses and Variants by Coordinated Recognition of a Virus Vulnerable Site Taishi Onodera, Shunsuke Kita, Yu Adachi, Saya Moriyama, Akihiko Sato, Takao Nomura, et al. (+29)
20 [GO] 2021―Aug―19 A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope Laura A. VanBlargan, Lucas J. Adams, Zhuoming Liu, Rita E. Chen, Pavlo Gilchuk, Saravanan Raju, et al. (+19)
21 [GO] 2021―Aug―18 Live Imaging of SARS-CoV-2 Infection in Mice Reveals that Neutralizing Antibodies Require Fc Function for Optimal Efficacy Irfan Ullah, Jérémie Prévost, Mark S. Ladinsky, Helen Stone, Maolin Lu, Sai Priya Anand, et al. (+27)
22 [GO] 2021―Aug―17 A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants Aaron J. Schmitz, Jackson S. Turner, Zhuoming Liu, Julian Q. Zhou, Ishmael D. Aziati, Rita E. Chen, et al. (+23)
23 [GO] 2021―Aug―13 Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination Mark M. Painter, Divij Mathew, Rishi R. Goel, Sokratis A. Apostolidis, Ajinkya Pattekar, Oliva Kuthuru, et al. (+26)
24 [GO] 2021―Aug―03 Accelerated COVID-19 vaccine development: milestones, lessons, and prospects Karin Bok, Sandra Sitar, Barney S. Graham, John R. Mascola
25 [GO] 2021―Jul―30 Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations Frauke Muecksch, Yiska Weisblum, Christopher O. Barnes, Fabian Schmidt, Dennis Schaefer-Babajew, Zijun Wang, et al. (+22)
26 [GO] 2021―Jul―13 COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead Marguerite Massinga Loembé, John N. Nkengasong
27 [GO] 2021―Jul―02 Temporal Maturation of Neutralizing Antibodies in COVID-19 Convalescent Individuals Improves Potency and Breadth to Circulating SARS-CoV-2 Variants Saya Moriyama, Yu Adachi, Takashi Sato, Keisuke Tonouchi, Lin Sun, Shuetsu Fukushi, et al. (+27)
28 [GO] 2021―Jul―02 COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge Anthony T. DiPiazza, Sarah R. Leist, Olubukola M. Abiona, Juan I. Moliva, Anne Werner, Mahnaz Minai, et al. (+19)
29 [GO] 2021―Jun―09 Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T cell interactions Marius Schwabenland, Henrike Salié, Jovan Tanevski, Saskia Killmer, Marilyn Salvat Lago, Alexandra Emilia Schlaak, et al. (+20)
30 [GO] 2021―Jun―08 Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species Ruoke Wang, Qi Zhang, Jiwan Ge, Wenlin Ren, Rui Zhang, Jun Lan, et al. (+14)
31 [GO] 2021―May―16 Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Laura Bergamaschi, Federica Mescia, Lorinda Turner, Aimee L. Hanson, Prasanti Kotagiri, Benjamin J. Dunmore, et al. (+31)
32 [GO] 2021―May―09 Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia Stefanie Kreutmair, Susanne Unger, Nicolás Gonzalo Núñez, Florian Ingelfinger, Chiara Alberti, Donatella De Feo, et al. (+20)
33 [GO] 2021―May―09 SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2 Qiao Lu, Jia Liu, Shuai Zhao, Maria Florencia Gomez Castro, Maudry Laurent-Rolle, Jianbo Dong, et al. (+44)
34 [GO] 2021―May―06 Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets Haley L. Dugan, Christopher T. Stamper, Lei Li, Siriruk Changrob, Nicholas W. Asby, Peter J. Halfmann, et al. (+26)
35 [GO] 2021―Apr―16 CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naïve precursor frequency and T cell receptor promiscuity Thi H.O. Nguyen, Louise C. Rowntree, Jan Petersen, Brendon Y. Chua, Luca Hensen, Lukasz Kedzierski, et al. (+36)
36 [GO] 2021―Apr―15 CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses Katie E. Lineburg, Emma J. Grant, Srividhya Swaminathan, Demetra S.M. Chatzileontiadou, Christopher Szeto, Hannah Sloane, et al. (+20)
37 [GO] 2021―Apr―15 Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children Anjali Ramaswamy, Nina N. Brodsky, Tomokazu S. Sumida, Michela Comi, Hiromitsu Asashima, Kenneth B. Hoehn, et al. (+26)
38 [GO] 2021―Apr―02 Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant Carl Graham, Jeffrey Seow, Isabella Huettner, Hataf Khan, Neophytos Kouphou, Sam Acors, et al. (+23)
39 [GO] 2021―Mar―12 Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19 Peter A. Szabo, Pranay Dogra, Joshua I. Gray, Steven B. Wells, Thomas J. Connors, Stuart P. Weisberg, et al. (+18)
40 [GO] 2021―Feb―10 COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses Agnes Bonifacius, Sabine Tischer-Zimmermann, Anna C. Dragon, Daniel Gussarow, Alexander Vogel, Ulrike Krettek, et al. (+19)
41 [GO] 2021―Feb―05 Modified Vaccinia Ankara Vector-Based Vaccine Protects Macaques from SARS-CoV-2 Infection, Immune Pathology and Dysfunction in the Lung Nanda Kishore Routhu, Narayanaiah Cheedarla, Sailaja Gangadhara, Venkata Satish Bollimpelli, Arun Kumar Boddapati, Ayalnesh Shiferaw, et al. (+26)
42 [GO] 2021―Jan―29 Leveraging the antiviral type-I interferon system as a first line defense against SARS-CoV-2 pathogenicity Daisy A. Hoagland, Rasmus Møller, Skyler A. Uhl, Kohei Oishi, Justin Frere, Ilona Golynker, et al. (+7)
43 [GO] 2021―Jan―23 B cell memory: Understanding COVID-19 Isaak Quast, David Tarlinton
44 [GO] 2020―Dec―23 Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid Michael Heming, Xiaolin Li, Saskia Räuber, Anne K. Mausberg, Anna-Lena Börsch, Maike Hartlehnert, et al. (+12)
45 [GO] 2020―Dec―19 T cell memory: Understanding COVID-19 Nicholas N. Jarjour, David Masopust, Stephen C. Jameson
46 [GO] 2020―Dec―15 PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19 Min-Seok Rha, Hye Won Jeong, Jae-Hoon Ko, Seong Jin Choi, In-Ho Seo, Jeong Seok Lee, et al. (+19)
47 [GO] 2020―Nov―26 Low avidity CD4+ T cell responses to SARS-CoV-2 in unexposed individuals and humans with severe COVID-19 Petra Bacher, Elisa Rosati, Daniela Esser, Gabriela Rios Martini, Carina Saggau, Esther Schiminsky, et al. (+21)
48 [GO] 2020―Nov―26 Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells and plasmablasts as hallmarks of severe COVID-19 trajectories Joana P. Bernardes, Neha Mishra, Florian Tran, Thomas Bahmer, Lena Best, Johanna I. Blase, et al. (+64)
49 [GO] 2020―Nov―25 Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity Hejun Liu, Nicholas C. Wu, Meng Yuan, Sandhya Bangaru, Jonathan L. Torres, Tom G. Caniels, et al. (+8)
50 [GO] 2020―Nov―25 Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses Xiancai Ma, Fan Zou, Fei Yu, Rong Li, Yaochang Yuan, Yiwen Zhang, et al. (+19)
51 [GO] 2020―Nov―21 SARS-CoV-2 mRNA vaccines foster potent antigen-specific germinal center responses associated with neutralizing antibody generation Katlyn Lederer, Diana Castaño, Daniela Gómez Atria, Thomas H. Oguin, Sidney Wang, Tomaz B. Manzoni, et al. (+15)
52 [GO] 2020―Nov―13 SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T cell receptors Alina S. Shomuradova, Murad S. Vagida, Savely A. Sheetikov, Ksenia V. Zornikova, Dmitry Kiryukhin, Aleksei Titov, et al. (+18)
53 [GO] 2020―Oct―23 Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses Jenna J. Guthmiller, Linda Yu-Ling Lan, Monica L. Fernández-Quintero, Julianna Han, Henry A. Utset, Dalia J. Bitar, et al. (+22)
54 [GO] 2020―Oct―20 Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19 Ting Shu, Wanshan Ning, Di Wu, Jiqian Xu, Qiangqiang Han, Muhan Huang, et al. (+18)
55 [GO] 2020―Oct―20 Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2, most of which are not located in the Spike protein Andrew P. Ferretti, Tomasz Kula, Yifan Wang, Dalena M.V. Nguyen, Adam Weinheimer, Garrett S. Dunlap, et al. (+13)
56 [GO] 2020―Oct―14 Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low Prevalence Communities and Reveal Durable Humoral Immunity. Tyler J. Ripperger, Jennifer L. Uhrlaub, Makiko Watanabe, Rachel Wong, Yvonne Castaneda, Hannah A. Pizzato, et al. (+31)
57 [GO] 2020―Aug―17 Implications of sex differences in immunity for SARS-CoV-2 pathogenesis and design of therapeutic interventions Madeleine Bunders, Marcus Altfeld
58 [GO] 2020―Aug―04 Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses Runhong Zhou, Kelvin Kai-Wang To, Yik-Chun Wong, Li Liu, Biao Zhou, Xin Li, et al. (+13)
59 [GO] 2020―Jul―30 A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice Dorottya Laczkó, Michael J. Hogan, Sushila A. Toulmin, Philip Hicks, Katlyn Lederer, Brian T. Gaudette, et al. (+36)
60 [GO] 2020―Jul―30 Distinct early serological signatures track with SARS-CoV-2 survival Caroline Atyeo, Stephanie Fischinger, Tomer Zohar, Matthew D. Slein, John Burke, Carolin Loos, et al. (+18)
61 [GO] 2020―Jul―19 Single-cell sequencing of peripheral blood mononuclear cells reveals distinct immune response landscapes of COVID-19 and influenza patients Linnan Zhu, Penghui Yang, Yingze Zhao, Zhenkun Zhuang, Zhifeng Wang, Rui Song, et al. (+38)
62 [GO] 2020―Jul―14 Lessons for COVID-19 immunity from other coronavirus infections Alan Sariol, Stanley Perlman
63 [GO] 2020―Jun―30 Next Generation Sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease Christoph Schultheiß, Lisa Paschold, Donjete Simnica, Malte Mohme, Edith Willscher, Lisa von Wenserski, et al. (+8)
64 [GO] 2020―Jun―28 Cytokine Storms: Understanding COVID-19 Nilam Mangalmurti, Christopher A. Hunter
65 [GO] 2020―Jun―23 The COVID-19 Serology Studies Workshop: Recommendations and Challenges Andrea M. Lerner, Robert W. Eisinger, Douglas R. Lowy, Lyle R. Petersen, Rosemary Humes, Matthew Hepburn, M. Cristina Cassetti
66 [GO] 2020―Jun―08 Analysis of a SARS-CoV-2 infected individual reveals development of potent neutralizing antibodies to distinct epitopes with limited somatic mutation Emilie Seydoux, Leah J. Homad, Anna J. MacCamy, K. Rachael Parks, Nicholas K. Hurlburt, Madeleine F. Jennewein, et al. (+14)
67 [GO] 2020―May―20 Respiratory virus infections: Understanding COVID-19 Kanta Subbarao, Siddhartha Mahanty
68 [GO] 2020―May―19 Herd Immunity: Understanding COVID-19 Haley E. Randolph, Luis B. Barreiro
69 [GO] 2020―May―08 SARS-CoV-2: Combating Coronavirus Emergence Rachel L. Graham, Ralph S. Baric
70 [GO] 2020―May―06 Immunology of COVID-19: current state of the science Nicolas Vabret, Graham J. Britton, Conor Gruber, Samarth Hegde, Joel Kim, Maria Kuksin, et al. (+25)
71 [GO] 2020―May―03 Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals Ling Ni, Fang Ye, Meng-Li Cheng, Yu Feng, Yong-Qiang Deng, Hui Zhao, et al. (+15)
72 [GO] 2020―Apr―22 COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome Toshio Hirano, Masaaki Murakami
73 [GO] 2020―Apr―06 SARS-CoV-2 Vaccines: Status Report Fatima Amanat, Florian Krammer
 [1] 

73 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.011 sec